Literature DB >> 29924642

Increased Cytokines at High Altitude: Lack of Effect of Ibuprofen on Acute Mountain Sickness, Physiological Variables, or Cytokine Levels.

Jenny Lundeberg1, John R Feiner2, Andrew Schober2, Jeffrey W Sall2, Helge Eilers2, Philip E Bickler2.   

Abstract

Lundeberg, Jenny, John R. Feiner, Andrew Schober, Jeffrey W. Sall, Helge Eilers, and Philip E. Bickler. Increased cytokines at high altitude: lack of effect of ibuprofen on acute mountain sickness, physiological variables or cytokine levels. High Alt Med Biol. 19:249-258, 2018.
INTRODUCTION: There is no consensus on the role of inflammation in high-altitude acclimatization. AIMS: To determine the effects of a nonsteroidal anti-inflammatory drug (ibuprofen 400 mg every 8 hours) on blood cytokines, acclimatization, acute mountain sickness (AMS, Lake Louise Score), and noninvasive oxygenation in brain and muscle in healthy volunteers.
MATERIALS AND METHODS: In this double-blind study, 20 volunteers were randomized to receive ibuprofen or placebo at sea level and for 48 hours at 3800 m altitude. Arterial, brain, and leg muscle saturation with near infrared spectroscopy, pulse oximetry, and heart rate were measured. Blood samples were collected for cytokine levels and cytokine gene expression.
RESULTS: All of the placebo subjects and 8 of 11 ibuprofen subjects developed AMS at altitude (p = 0.22, comparing placebo and ibuprofen). On arrival at altitude, the oxygen saturation as measured by pulse oximetry (SpO2) was 84.5% ± 5.4% (mean ± standard deviation). Increase in blood interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), tumor necrosis factor-α (TNF-α), and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels occurred comparably in the placebo and ibuprofen groups (all not significant, univariate test by Wilcoxon rank sum). Increased IL-6 was associated with higher AMS scores (p = 0.002 by Spearman rank correlation). However, we found no difference or association in AMS score and blood or tissue oxygenation between the ibuprofen and placebo groups.
CONCLUSIONS: We found that ibuprofen, at the package-recommended adult dose, did not have a significant effect on altitude-related increases in cytokines, AMS scores, blood, or tissue oxygenation in a population of healthy subjects with a high incidence of AMS.

Entities:  

Keywords:  acclimatization; acute mountain sickness; altitude; altitude sickness; anti-inflammatory agents nonsteroidal; cytokines

Mesh:

Substances:

Year:  2018        PMID: 29924642     DOI: 10.1089/ham.2017.0144

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  8 in total

1.  Expression Profiles of Long Noncoding RNAs in Mice with High-Altitude Hypoxia-Induced Brain Injury Treated with Gymnadenia conopsea (L.) R. Br.

Authors:  Yongcang Zhang; Lan Liu; Cuiting Liang; Lingyu Zhou; Lixia Tan; Yonghua Zong; Lili Wu; Tonghua Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-12       Impact factor: 2.570

2.  Hypoxic-inflammatory responses under acute hypoxia: In Vitro experiments and prospective observational expedition trial.

Authors:  Tobias Kammerer; Valentina Faihs; Nikolai Hulde; Manfred Stangl; Florian Brettner; Markus Rehm; Mareike Horstmann; Julia Kröpfl; Christina Spengler; Simone Kreth; Simon Schäfer
Journal:  Int J Mol Sci       Date:  2020-02-04       Impact factor: 5.923

Review 3.  The Use of Pulse Oximetry in the Assessment of Acclimatization to High Altitude.

Authors:  Tobias Dünnwald; Roland Kienast; David Niederseer; Martin Burtscher
Journal:  Sensors (Basel)       Date:  2021-02-10       Impact factor: 3.576

4.  Extreme altitude induces divergent mass reduction of right and left ventricle in mountain climbers.

Authors:  Camilla Udjus; Ivar Sjaastad; Ulla Hjørnholm; Torbjørn K Tunestveit; Pavel Hoffmann; Alexis Hinojosa; Emil K S Espe; Geir Christensen; Ole H Skjønsberg; Karl-Otto Larsen; Morten Rostrup
Journal:  Physiol Rep       Date:  2022-02

5.  Comparison of cytokines levels among COVID-19 patients living at sea level and high altitude.

Authors:  Juana Del Valle-Mendoza; Yordi Tarazona-Castro; Alfredo Merino-Luna; Hugo Carrillo-Ng; Sungmin Kym; Miguel Angel Aguilar-Luis; Luis J Del Valle; Ronald Aquino-Ortega; Johanna Martins-Luna; Isaac Peña-Tuesta; Wilmer Silva-Caso
Journal:  BMC Infect Dis       Date:  2022-01-28       Impact factor: 3.090

6.  High Altitude Cerebral Edema: Improving Treatment Options.

Authors:  Rebecca Zelmanovich; Kevin Pierre; Patrick Felisma; Dwayne Cole; Matthew Goldman; Brandon Lucke-Wold
Journal:  Biologics (Basel)       Date:  2022-03-17

7.  Inflammatory gene expression during acute high-altitude exposure.

Authors:  Kathy Pham; Shyleen Frost; Keval Parikh; Nikhil Puvvula; Britney Oeung; Erica C Heinrich
Journal:  J Physiol       Date:  2022-08-17       Impact factor: 6.228

8.  Prophylaxis of ibuprofen in acute mountain sickness: A protocol for systematic review and meta-analysis.

Authors:  Hai Yi; Kuiying Wang; Xinyu Gan; Li Li; Qian Zhang; Jiao Xiang; Xiuwei Yuan; Yugang Zhang; Yonghua Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.